くすりのしおり

Injection
Revised: 8/2018

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Edaravone I.V. Drip Infusion Bag 30mg "Nichiiko"
 Active ingredient:
Edaravone
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine eliminates harmful free radicals which increase in cerebral region with poor blood flow to protect brain.
It is usually used to improve neurological symptoms, activity disorder of daily living and functional disorder accompanied with acute ischemic stroke.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have renal dysfunction.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, inject by intravenous infusion twice a day.
  • This medicine will be administered according to symptoms of the patient. The duration of use is within 14 days.

Precautions while taking this medicine

  • When this medicine is administered, the examination of liver/renal function and blood tests will be taken frequently (frequency of these examinations varies according to your symptoms).

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include rash, redness, swelling, wheal, itch and erythema (erythema multiforme exudativum, etc.). If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • decreased urine output, edema of limbs and face, respiratory distress [acute renal failure, nephrotic syndrome]
  • general malaise, loss of appetite, yellowing of the skin and the white of eyes [fulminant hepatitis, liver dysfunction, jaundice]
  • nasal/gum bleeding, high fever [thrombocytopenia, granulocytopenia]
  • bruise, nose/gum bleeding, bloody urine [disseminated intravascular coagulation syndrome]
  • fever, cough, respiratory distress [acute lung disorder]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z